Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
5.4
3.9
Journals
JCM
Special Issues
Sleeve Gastrectomy: Risks, Outcomes, and Complications
share announcement

Sleeve Gastrectomy: Risks, Outcomes, and Complications

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "General Surgery".

Deadline for manuscript submissions: 25 July 2024 | Viewed by 4050

Special Issue Editor

Prof. Dr. Shinnichi Okazumi

E-Mail Website
Guest Editor
Department of Surgery, Toho University Sakura Medical Center, 564-1 Shimoshizu, Sakura, Chiba 285-8741, Japan
Interests: digestive surgery; gastrono intestinal surgery

Special Issue Information

Dear Colleagues,

Currently, it is widely recognized that obesity leads to complications of various diseases and the shortening of survival time, and it has been also reported as a high risk factor for COVID-19 severity. Thus, obesity treatment has become a global medical issue. Among the benefits, it was found that surgical treatment for severe obesity can improve the status of various metabolic diseases in addition to the weight loss effect, which was the original purpose for its initiation in the 1950s, and it has recently been referred to as “metabolic surgery”. Currently, around 800,000 such surgeries are performed annually worldwide, and the number of sleeve gastrectomy operations is increasing. Although the surgical procedure is simple, detailed perioperative care must be taken to prevent postoperative several complications. Short-term complications include bleeding and anastomotic insufficiency, and long-term complications include gastroesophageal reflux (GERD), stenosis, and poor weight loss. Therefore, the estimation of operative indication, risk assessment, perioperative management, and follow-up management are important, and revision surgery should be required for patients with poor long-term results. In this Special Issue, we aim to analyze risk assessment, therapeutic effect, and complications in severe obesity treatment by sleeve gastrectomy to for improved outcomes.

Prof. Dr. Shinnichi Okazumi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • sleeve gastrectomy
  • risk factor
  • GERD
  • COVID-19
  • revision surgery

Published Papers (4 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Review

Jump to: Other

20 pages, 8482 KiB  
Review
Endoscopic Management of Post-Sleeve Gastrectomy Complications
by Muaaz Masood, Donald E. Low, Shanley B. Deal and Richard A. Kozarek
J. Clin. Med. 2024, 13(7), 2011; https://doi.org/10.3390/jcm13072011 - 29 Mar 2024
Viewed by 799
Abstract
Obesity is associated with several chronic conditions including diabetes, cardiovascular disease, and metabolic dysfunction-associated steatotic liver disease and malignancy. Bariatric surgery, most commonly Roux-en-Y gastric bypass and sleeve gastrectomy, is an effective treatment modality for obesity and can improve associated comorbidities. Over the [...] Read more.
Obesity is associated with several chronic conditions including diabetes, cardiovascular disease, and metabolic dysfunction-associated steatotic liver disease and malignancy. Bariatric surgery, most commonly Roux-en-Y gastric bypass and sleeve gastrectomy, is an effective treatment modality for obesity and can improve associated comorbidities. Over the last 20 years, there has been an increase in the rate of bariatric surgeries associated with the growing obesity epidemic. Sleeve gastrectomy is the most widely performed bariatric surgery currently, and while it serves as a durable option for some patients, it is important to note that several complications, including sleeve leak, stenosis, chronic fistula, gastrointestinal hemorrhage, and gastroesophageal reflux disease, may occur. Endoscopic methods to manage post-sleeve gastrectomy complications are often considered due to the risks associated with a reoperation, and endoscopy plays a significant role in the diagnosis and management of post-sleeve gastrectomy complications. We perform a detailed review of the current endoscopic management of post-sleeve gastrectomy complications. Full article
(This article belongs to the Special Issue Sleeve Gastrectomy: Risks, Outcomes, and Complications)
►▼ Show Figures

Graphical abstract

14 pages, 2370 KiB  
Review
The Art of Sleeve Gastrectomy
by Shahed Tish and Ricard Corcelles
J. Clin. Med. 2024, 13(7), 1954; https://doi.org/10.3390/jcm13071954 - 28 Mar 2024
Viewed by 785
Abstract
Sleeve gastrectomy (SG) has historically evolved from gastroplasty and anti-reflux procedures into one of the most commonly performed primary metabolic surgeries in the United States and worldwide. Initially initiated in the 1980s as part of the duodenal switch procedure, its standalone effectiveness and [...] Read more.
Sleeve gastrectomy (SG) has historically evolved from gastroplasty and anti-reflux procedures into one of the most commonly performed primary metabolic surgeries in the United States and worldwide. Initially initiated in the 1980s as part of the duodenal switch procedure, its standalone effectiveness and simplicity have led to increasing popularity globally. The rise in obesity rates transcends age boundaries, alarmingly affecting not only adults but also the younger demographic. This escalating trend is concerning, as it predisposes these populations to numerous future health complications, as well as highlighting the critical necessity for a safe and potent weight loss strategy. Although sleeve gastrectomy carries a higher risk for gastroesophageal reflux disease (GERD) compared to other bariatric procedures, it stands out as a reliable, safe and effective surgical solution for obesity. It is particularly beneficial for adolescents and patients with complex medical comorbidities, including, but not limited to, heart failure and immunocompromisation. It has also served as a bridge for transplants in morbidly obese patients with end-stage heart, liver and kidney disease due to its favorable safety profile. Full article
(This article belongs to the Special Issue Sleeve Gastrectomy: Risks, Outcomes, and Complications)
►▼ Show Figures

Figure 1

21 pages, 5765 KiB  
Review
Current Management and Treatment Paradigms of Gastroesophageal Reflux Disease following Sleeve Gastrectomy
by Muaaz Masood, Donald E. Low, Shanley B. Deal and Richard A. Kozarek
J. Clin. Med. 2024, 13(5), 1246; https://doi.org/10.3390/jcm13051246 - 22 Feb 2024
Viewed by 923
Abstract
Obesity is associated with serious comorbidities and economic implications. Bariatric surgery, most commonly Roux-en-Y gastric bypass and sleeve gastrectomy, are effective options for weight loss and the improvement of obesity-related comorbidities. With the growing obesity epidemic, there has been a concomitant rise in [...] Read more.
Obesity is associated with serious comorbidities and economic implications. Bariatric surgery, most commonly Roux-en-Y gastric bypass and sleeve gastrectomy, are effective options for weight loss and the improvement of obesity-related comorbidities. With the growing obesity epidemic, there has been a concomitant rise in bariatric surgeries, particularly in sleeve gastrectomy, which has been the most widely performed bariatric surgery since 2013. Gastroesophageal reflux disease (GERD) is highly prevalent in obese individuals, can significantly impact quality of life and may lead to serious complications. Obesity and GERD both improve with weight loss. However, as the incidence of sleeve gastrectomy rises, recent data have revealed a risk of exacerbation of pre-existing GERD or the development of de novo GERD following sleeve gastrectomy. We performed a detailed review of GERD post-sleeve gastrectomy, including its overall incidence, pathophysiology and current treatment paradigms. Full article
(This article belongs to the Special Issue Sleeve Gastrectomy: Risks, Outcomes, and Complications)
►▼ Show Figures

Graphical abstract

Other

Jump to: Review

7 pages, 1079 KiB  
Brief Report
Verification of Safety and Efficacy of Sleeve Gastrectomy Based on National Registry by Japanese Society for Treatment of Obesity
by Shinichi Okazumi, Takashi Oshiro, Akira Sasaki, Hisahiro Matsubara and Ichiro Tatsuno
J. Clin. Med. 2023, 12(13), 4303; https://doi.org/10.3390/jcm12134303 - 27 Jun 2023
Cited by 2 | Viewed by 796
Abstract
In Japan, bariatric surgical treatment was started in 1982. The Japanese Society for Treatment of Obesity (JSTO) was established in 2007, and then, JSTO started the national registry of bariatric surgery cases and multidisciplinary educational program. A total of 44 facilities registered 4055 [...] Read more.
In Japan, bariatric surgical treatment was started in 1982. The Japanese Society for Treatment of Obesity (JSTO) was established in 2007, and then, JSTO started the national registry of bariatric surgery cases and multidisciplinary educational program. A total of 44 facilities registered 4055 bariatric surgical cases until 2021. In this study, the purpose is to clarify the indication, the safety and the effectiveness of the sleeve gastrectomy using national registry database compiled by JSTO. Preoperative BMI ranged from 27.6 to 90.7 kg/m2, and the mean value was 42.7. With regard to gender, men/women was 1/1.3. Age was 42.2 as mean. As preoperative comorbidities, DM ratio was 54.4% of the patients, hypertension 64.5%, dyslipidemia 65.1%, and sleep apnea syndrome 69.8%. As an operation method, laparoscopic method was conducted in 99.7% of the cases. The intraoperative incidence rate was 0.9%. Conversion rate to open method was 1.1%. Postoperative morbidity ratio was 5.6%, and mortality was 0%. Reoperations were performed in 1.5% of the cases. Postoperative hospital stay was 5 days in median value. Body weight loss was 27.6 kg in the mean value after follow-up days of 279 ± 245. As the effect on the preoperative metabolic comorbidities, DM has improved in 82.9% of the cases, hypertension 67.9% and dyslipidemia 66.6%. In conclusion, using JSTO database, we evaluated the indication, postoperative complications and weight loss effect of sleeve gastrectomy in Japan. Regarding the evaluation of the effect on preoperative comorbidities, future follow-up based on more detailed criteria was considered to be necessary. Full article
(This article belongs to the Special Issue Sleeve Gastrectomy: Risks, Outcomes, and Complications)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-4
Back to TopTop